Prevalere Life Sciences has opened a new biotechnology lab at its Whitesboro, NY headquarters, enhancing the current 48,000-sq.-ft. facility and housing seven labs. The company transformed unfinished space into a 1,800-sq.-ft. immunoassay lab, where it will conduct pharmacokinetic and immunogenicity testing.
   
“Over the last six years that we have been working in the biotechnology field, we’ve seen many breakthrough therapies emerging, leading to increased demand from our clients that required an expansion in this area” said Dr. Mario Rocci, Jr., Prevalere's chief executive officer. “We see this expansion as another opportunity to advance our mission of providing innovative R&D services to meet the evolving needs of the pharmaceutical and biotechnology communities.”
   
This expansion is considered to be Phase I of a two-phase project to meet future demand increases with a second new lab that could be up and running within 60 days. Prevalere has relocated its current team of immunoassay scientists to this new wing of the facility, and plans to hire more scientists in this area. Twenty employees were added in 2007, and seven more employees have been added this year to date.